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The 2nd Affiliated Hospital of Wenzhou Medical University, Wenzhou, China 2 University of Mississippi Medical Center, Jackson, Mississippi, USA Objective: The objective of this study is to evaluate the role of venous return on venous congestion and flap survival of the arterialized venous flaps (AVFs). Materials and Methods: A 10×8-cm skin flap was designed symmetrically in the rabbit abdomen. Four groups were included: the conventional arterial perfusion flap as the control group and 3 experimental groups. The experimental groups I, II, and III were designed based on the number of drainage veins (1 drainage vein for experimental group I, 2 for group II, and 3 for group III). The thoracoepigastric arteries and veins and 1 femoral artery were used as vascular sources. Levels of epidermal metabolite, water content, status of vascular perfusion, and flap viability in each group were observed and analyzed. Results: In contrast to the control group, significant venous congestion assessed by water content was noted in all the 3 experimental groups and the most severe one was found in the experimental group I, while no statistical difference was observed between the experimental groups II and III. Similar results regarding blood perfusion state, epidermal metabolite levels, and flap survival status were obtained among the 3 experimental groups. Conclusions: Venous return is vital in the survival of AVFs, but the problem of venous congestion can only be partially solved by increasing the number of draining veins. Further studies are warranted to gain insight into this complicated issue.
Novel Drug Therapy Improved Nerve Regeneration and Function
Joaquim Forés 1 , David Romeo-Guitart 2,3 , Francisco González-Pérez 2,3 , Xavier Navarro 2,3 , and Caty Casas 1 Background: Injured peripheral nerves regenerate their lost axons but functional recovery in humans is frequently disappointing. This is particularly important when injuries require regeneration over long distances and/or over long time periods. In addition, neurotmesis caused by nerve root avulsion may lead to a progressive loss of axotomized motoneurons (MNs) which sometimes avert warranty for surgical nerve repair. Using a bottom-up experimental approach using rat models of peripheral nerve injuries and sophisticate molecular biology and computational tools we ended up with a selected combination of FDA-approved drugs repurposed for its unexpected use in traumatology. In previous studies, using experimental models of nerve root avulsion, we validated that the drug combination (C1) exerted neuroprotection of almost 60% of spinal motoneurons (MNs) and exhibited anti-inflammatory properties reducing glial reactivity. Currently, we aim to verify the regenerative potential of C1. Methods: We use a model of crush injury in rat (Sprague Dawley) sciatic nerve. To asses functional recovery of denervated muscles, the compound muscle action potentials (CMAP) evoked in response to sciatic nerve stimulation were recorded in gastrocnemius and plantar muscles during the follow up. The recovery of locomotion function was assessed by the walking track analysis. At end point, we analysed neuromuscular junction's reinnervation by plantar muscle immunohistochemistry. Results:
We are now presenting that in a crush model of the sciatic nerve, the animals treated with oral administrated C1 presented acceleration in nerve regeneration analysed by electrophysiological recordings. Treated rats presented around 40 and 60% of increased amplitude of the CMAP of the
